Advertisement
Research Article| Volume 9, ISSUE 1, P29-36, March 1989

Screening for High Blood Cholesterol

  • Beth Schucker
    Correspondence
    Corresponding author: Lipid Metabolism-Artherogenesis Branch, Federal Building, Room 401, 7550 Wisconsin Avenue Bethesda, Maryland 20892.
    Affiliations
    Health Scientist Administrator, Lipid Metabolism-Atherogenesis Branch, Division of Heart and Vascular Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland
    Search for articles by this author
  • Reagan H. Bradford
    Affiliations
    Special Expert, Lipid Metabolism-Atherogenesis Branch, Division of Heart and Vascular Diseases, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland

    Director, Oklahoma Lipid Research Clinic, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30640-1
Screening for High Blood Cholesterol
Previous ArticleNew Guidelines for Lowering Blood Cholesterol
Next ArticleThe Need for Accurate Total Cholesterol Measurement: Recommended Analytical Goals, Current State of Reliability, and Guidelines for Better Determinations
      This paper is only available as a PDF. To read, Please Download here.
      The detection and treatment goals set forth by the National Cholesterol Education Program will require a screening effort of considerable magnitude. Much of this screening can be accomplished through routine medical care, but screenings conducted at public or community sites also offer promise. Ongoing screening research is addressing many of the issues involved in public screening and will provide a basis for screening guidelines. With such guidelines in place, it is hoped that public screening might make a meaningful contribution to the national effort to reduce the risk of coronary heart disease through the control of blood cholesterol.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Aronow W.S.
        • Allen W.H.
        • DeCristofaro D.
        • et al.
        Follow-up of mass screening for coronary risk factors in 1,817 adults.
        Circulation. 1975; 51: 1038
        • Bachorik P.S.
        • Bradford R.H.
        • Roberts K.
        • et al.
        Accuracy and precision of total cholesterol analyses performed with the Reflotron cholesterol method.
        Submitted for publication. 1988;
        • Belsey R.
        • Goitein R.K.
        • Baer D.M.
        Evaluation of a laboratory system intended for use in physicians′ offices: I. Reliability of results produced by trained laboratory technologists.
        JAMA. 1987; 258: 353
        • Belsey R.
        • Vandenbark M.
        • Goitein R.K.
        • et al.
        Evaluation of a laboratory system intended for use in physicians′ offices: II. Reliability of results produced by health care workers without formal or professional laboratory training.
        JAMA. 1987; 258: 357
        • Berwick D.M.
        Screening in health fairs: A critical review of benefits, risks, and costs.
        JAMA. 1985; 254: 1492
        • Blair T.P.
        • Bryant F.J.
        • Bocuzzi S.
        Treatment of hypercholesterolemia by a clinical nurse using a stepped-care protocol in a nonvolunteer population.
        Arch Intern Med. 1988; 148: 1046
        • Block L.
        • Banspach S.W.
        • Gans K.
        • et al.
        Impact of public education and continuing education on physician attitudes and behavior concerning cholesterol.
        Am J Prev Med. 1988; 4: 255

      8. Bradford RH, Bachorik PS, Roberts K, et al: Feasibility of blood cholesterol screening in several environments using a portable dry-chemistry analyzer and fingerstick blood samples: Screening results and reported follow-up by referred screenees. Eur Heart J, in press

        • Brook J.G.
        • Rifkind B.M.
        Cholesterol and coronary heart disease prevention—A trans Atlantic consensus.
        Submitted for publication. 1988;
        • Burke J.J.
        • Fischer P.M.
        A clinician′ guide to office measurement of cholesterol.
        JAMA. 1988; 259: 3444
        • Current status of blood cholesterol measurement in clinical laboratories in the United States
        A report from the Laboratory Standardization Panel of the National Cholesterol Education Program.
        Clin Chem. 1988; 34: 193
        • Fischer P.M.
        • Addison L.A.
        • Koneman E.W.
        • et al.
        Education and the physician′s office laboratory.
        JAMA. 1986; 255: 1464
        • Greenland P.
        • Levenkron J.C.
        • Radley M.G.
        • et al.
        Feasibility of large-scale cholesterol screening: Experience with a portable capillary-blood testing device.
        Am J Public Health. 1987; 77: 73
        • Havas S.
        • Greenland P.
        • Wones R.
        • et al.
        Addressing unanswered questions about population cholesterol screenings: The model systems for blood cholesterol screening program.
        Am J Prev Med. 1988; (in press)
        • Jones A.
        • Davies D.H.
        • Dove J.R.
        • et al.
        Identification and treatment of risk factors for coronary heart disease in general practice: A possible screening model.
        Br Med J. 1988; 296: 1711
        • Koch T.R.
        • Mehta U.
        • Lee H.
        • et al.
        Bias and precision of cholesterol analysis by physician′s office analyzers.
        Clin Chem. 1987; 33: 2262
        • Leads from the Morbidity and Mortality Weekly Report
        Cholesterol awareness in selected states—behavioral risk factor surveillance, 1987.
        JAMA. 1988; 259: 2969
        • Lenfant C.
        • Roccella E.J.
        Trends in hypertension control in the United States.
        Chest. 1984; 16: 459
      19. Lowering blood cholesterol to prevent heart disease, Consensus Conference.
        JAMA. 1985; 254: 2080
        • Morrison A.
        Screening and chronic disease.
        Oxford University Press, New York1985
        • Murray D.M.
        • Luepker R.V.
        • Pirie P.L.
        • et al.
        Systematic risk factor screening and education: A community-wide approach to prevention of coronary heart disease.
        Prev Med. 1986; 15: 661

      22. National Cholesterol Conference: Office of Prevention, Education and Control, National Heart, Lung, and Blood Institute, Bethesda, MD, 1988

      23. Physician Visits: Volume and Interval Since Last Visit, United States, 1980.
        DHHS Publication No. (PHS) 83-1572. National Center for Health Statistics, Hyattsville, MD1983

      24. Public screening for measuring blood cholesterol—issues for special concern. Office of Prevention, Education, and Control: National Heart, Lung, and Blood Institute, Bethesda, MD, 1987

      25. Report of the national cholesterol education program expert panel on detection evaluation and treatment of high blood cholesterol in adults.
        Arch Intern Med. 1988; 148: 36
        • Rifkind B.M.
        • Lenfant C.
        Cholesterol lowering and the reduction of coronary heart disease risk.
        JAMA. 1986; 256: 2872
        • Schucker B.
        • Bailey K.
        • Heimbach J.T.
        • et al.
        Change in public perspective on cholesterol and heart disease: Results from two national surveys.
        JAMA. 1987; 258: 3527
        • Schucker B.
        • Wittes J.T.
        • Cutler J.A.
        • et al.
        Change in physician perspective on cholesterol and heart disease: Results from two national surveys.
        JAMA. 1987; 258: 3521
        • Strategies for the prevention of coronary heart disease
        A policy statement of the European Atherosclerosis Society.
        Eur Heart J. 1987; 8: 77
        • Wynder E.
        • Field F.
        • Haley N.
        Population screening for cholesterol determinations: A pilot study.
        JAMA. 1986; 256: 2839

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30640-1

      Copyright

      © 1989 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX